What this episode is about
80 percent of women get menopausal symptoms. Five percent get treated for them.
Key takeaways
- The 2003 black box warning on all estrogen products, including local vaginal estrogen, traced back to the 2002 Women's Health Initiative study, whose headline reached the media before the underlying statistics were released or held up to scrutiny.
- No clinical trial has shown hormone therapy increases breast cancer mortality, and women who took estrogen alone in the WHI study saw a 24% reduction in breast cancer.
- Over 40 observational studies cited at the FDA press conference show hormone therapy users had 30 to 50% less coronary heart disease, 30% less all-cause mortality, 48% fewer fatal heart attacks, and 50 to 60% fewer bone fractures.
Moments from this episode
Word for word from the recording. Tap a time to hear it.
Science triumphed over fear
“But yesterday, that changed. Science triumphed over fear. Evidence overcame dogma and women's voices were finally heard at the highest levels of government.”
Every woman deserves accurate information
“This doesn't mean every woman should take hormone therapy. It means every woman deserves accurate information to make informed decisions based on her individual health history and in partnership with a qualified provider.”
Moving forward with knowledge and hope
“22 years of fear-based medicine have ended. A new era of evidence-based women's health care has begun. Yesterday's FDA announcement removed the barriers of fear. Today, you get to move forward with knowledge, agency, and hope.”
“After 22 years of advocacy, research, and relentless determination from countless women, clinicians, and organizations, the change we've been fighting for is finally here.”
Gabriella Espinosaat 0:10
Hear this momentFeel more pleasure, 10 minutes a day.
10 Days of Pleasure is free. One 10-minute turn-on in your inbox each day. Each one comes with the expert from my podcast who explains why it works.
Day 1 lands in your inbox in a minute. My letter comes after the 10 days, and you can unsubscribe any time.
Show notes
This solo episode covers the FDA's decision this week to remove the 22-year-old black box warning from vaginal and systemic estrogen therapies. Gabriella traces the fear back to the 2002 Women's Health Initiative study, whose alarming headline reached the media before the underlying data was released, and explains how local, minimally-absorbed vaginal estrogen got swept into warnings designed for systemic hormones. She walks through what the evidence shows now: no clinical trial has found hormone therapy raises breast cancer mortality, and multiple studies show benefits for bone density, heart disease risk, and genitourinary symptoms. The argument closes by naming the human cost of the old warning, an estimated 50 million women denied or avoiding treatment over 23 years.
Read the full show notesShow less
Have you been living with debilitating hot flashes, sleepless nights, or painful intercourse because you're terrified hormone therapy will give you cancer? What if everything you've been told about menopause treatment has been wrong?
In this urgent episode of Pleasure In the Pause, host Gabriella Espinosa reveals a seismic shift in women's healthcare: the FDA has just eliminated the fear-based black box warnings that have kept millions of women from accessing hormone therapy for over two decades. This isn't just a policy change, it's a complete vindication of the science that's been buried under misinformation since 2002.
Discover why vaginal estrogen was never dangerous, how hormone therapy can add up to a decade of healthy years to your life, and what the research actually shows about breast cancer risk (spoiler: it's not what you think). If you've been suffering in silence or second-guessing treatment options, this episode will arm you with the facts you need to take control of your menopause journey.
Highlights from our discussion include:
- A Misinterpreted Study Created Two Decades of Unnecessary Suffering: The 2002 Women's Health Initiative findings were released to media before scientists could properly analyze them, creating widespread panic that wasn't supported by the actual data. An estimated 50 million women avoided or were denied treatment as a result.
- The Real Breast Cancer Numbers Tell a Different Story: Women taking estrogen alone saw their breast cancer risk drop by 24%. Meanwhile, no study has ever demonstrated that hormone replacement therapy increases breast cancer death rates, but this nuance was lost in the fearmongering.
- Hormone Therapy Rivals Statins for Heart Protection (But Nobody Talks About It): While statins show up to 35% reduction in heart disease risk, HRT demonstrates up to 50% reduction - yet heart disease remains the number one killer of women. The research also shows dramatic reductions in bone fractures and overall mortality when treatment begins at the right time.
- Your Symptoms Aren't "Just Part of Aging" and They're Not Trivial: Over 80% of women experience menopausal symptoms that last an average of eight years, with many finding them severe enough to impact work, relationships, and quality of life. Only 5% currently receive treatment, and nearly one in three women who get prescriptions never use them because of fear created by warning labels.
- Timing Is Everything for Maximum Benefit: Starting hormone therapy during perimenopause or within a decade of menopause onset unlocks protective effects for your brain, heart, bones, and metabolic health. This treatment window is when estrogen functions as a longevity intervention, not just symptom relief.
The era of dismissing, minimizing, and scaring women away from effective treatment is over.
This FDA decision represents more than regulatory housekeeping - it's a fundamental shift in how women's health is valued and treated. But knowing your options exist is only the first step. Now it's time to advocate for yourself.
Start tracking your symptoms today. Research menopause-certified practitioners in your area. Explore resources from the North American Menopause Society or listen to Pleasure In the Pause Episode 34 for a deep dive on hormone therapy benefits and lifestyle factors. Whether you ultimately choose hormone therapy or not, you deserve to make that decision based on accurate science, not decades-old fear tactics.
And here's how you can be part of the solution: Share this episode. Every woman who hears this information is one step closer to reclaiming her health, her comfort, and her power. The grassroots advocacy that made this FDA decision possible, including the 26,000+ signatures collected by Let's Talk Menopause, proves that our voices matter.
If you're seeking to reclaim your pleasure and vitality, join Gabriella at pleasureinthepause.com for this enlightening journey into the heart of female pleasure and empowerment.
LINKS MENTIONED:
CONNECT WITH GABRIELLA ESPINOSA:
The information shared on Pleasure in the Pause is for educational and informational purposes only and is not intended as medical advice. Always consult your healthcare provider before making any decisions about your health or treatment. The views expressed by guests are their own and do not necessarily reflect the views of the host or Pleasure in the Pause.
About your host
Gabriella EspinosaI talk with doctors and experts about pleasure, desire and feeling fully alive in midlife. This one's just me.More about me
